Information Provided By: 
Fly News Breaks for September 21, 2018
BLUE
Sep 21, 2018 | 06:01 EDT
Goldman Sachs analyst Salveen Richter removed Bluebird Bio from his firm's Americas Conviction List but keeps a Buy rating on the name with a $288 price target. The rating change is is not driven by concerns around Bluebird's pipeline execution or emerging competitive threats, Richter tells investors in a research note. The analyst just believes appreciation of key aspects of his investment thesis are better reflected in the shares at current valuation levels.
News For BLUE From the Last 2 Days
There are no results for your query BLUE
